Drug study checks if ethnicity affects maribavir levels
NCT ID NCT04497883
First seen Nov 01, 2025 · Last updated Jun 11, 2026 · Updated 27 times
Summary
This study looked at how the body processes a single dose of maribavir in healthy Japanese and Caucasian adults. Researchers wanted to see if there are differences in drug levels and safety between the two groups. The goal is to help determine the right dose for Japanese patients in future studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
PPD Development, LP
Las Vegas, Nevada, 89113, United States
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.